RxAll Inc. is a health information technology and big data startup company.

[5] Like many start-ups, RxAll Inc. came up against early challenges[6] when it almost ran out of cash in the first quarter of 2017, the founding team persisted to raise funds in parallel to operating the business.

[7] Co-founders Adebayo Alonge and Amy Kao managed to raise about $1 million in grants and bootstrapped funds from the Nigerian government, the Yale start-up ecosystem, Merck, Villgro and other support networks.

[8] The device is in use by country FDAs, Hospitals, Pharmacies and Big Pharma across the world.

[11][12] The company gained market entry into East Africa (Kenya and Uganda), West Africa (Nigeria and Ghana), Southeast Asia (Myanmar, Malaysia and Singapore), and the Americas (Canada, United States and Colombia).